ITGAE and neoplasm: Given the profound association of intratumoral stimulatory DCs with patient outcome,34 we sought to determine whether expansion of CD103+ DCs in the TME would enhance the therapeutic efficacy of the combined treatment by promoting tumor antigen presentation and priming of T cells following virotherapy-mediated ICD.35